ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,607Medicare Part D Prescriptions Filled, Including Refills
$662K Total Retail Price of All Prescriptions
316 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
AMLODIPINE BESYLATE 428 425
LOSARTAN POTASSIUM 379 378
LEVOTHYROXINE SODIUM 306 260
LOVASTATIN 288 288
FUROSEMIDE 271 268
METOPROLOL SUCCINATE 255 239
ALENDRONATE SODIUM 247 238
SIMVASTATIN 216 213
ATORVASTATIN CALCIUM 193 173
ALLOPURINOL 192 192
EXFORGE 184 166
HYDROCODONE-ACETAMINOPHEN 174 120 S3
POTASSIUM CHLORIDE 173 163
PANTOPRAZOLE SODIUM 142 133
METFORMIN HCL ER 142 142
WARFARIN SODIUM 140 138
DIOVAN 134 133
BENAZEPRIL HCL 125 125
LISINOPRIL 121 116
AMLODIPINE BESYLATE-BENAZEPRIL 117 117
CELEBREX 99 99
NEXIUM 97 95
DIGOXIN 93 89
OMEPRAZOLE 93 75
GABAPENTIN 87 80
DONEPEZIL HCL 87 87
METOPROLOL TARTRATE 85 76
TAMSULOSIN HCL 82 82
AZOR 79 78
CLONIDINE HCL 76 56
LOSARTAN-HYDROCHLOROTHIAZIDE 75 75
LEVEMIR FLEXPEN 75 68
SPIRIVA 74 63
CLOPIDOGREL 74 74
ZOLPIDEM TARTRATE 74 72
COLCRYS 73 71
VERAPAMIL ER 68 68
ADVAIR DISKUS 67 65
LANTUS SOLOSTAR 67 63
AZITHROMYCIN 66 61
BENICAR 64 64
METFORMIN HCL 62 53
FELODIPINE ER 61 61
SERTRALINE HCL 61 60
POLYETHYLENE GLYCOL 3350 60 60
BYSTOLIC 59 59
FENTANYL 58 58 S2
NAMENDA 57 57
BENICAR HCT 53 41
PLAVIX 52 52
CITALOPRAM HBR 51 39
HYDROCHLOROTHIAZIDE 50 50
PROAIR HFA 50 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.